Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Chih Ming Su"'
Autor:
Hsieh-Tsung Shen, Chin-Sheng Hung, Clilia Davis, Chih-Ming Su, Li-Min Liao, Hsiu-Ming Shih, Kuan-Der Lee, Muhamad Ansar, Ruo-Kai Lin
Publikováno v:
Biomolecules, Vol 14, Iss 5, p 571 (2024)
Breast cancer is a leading cause of cancer mortality in women worldwide. Using the Infinium MethylationEPIC BeadChip, we analyzed plasma sample methylation to identify the SRCIN1 gene in breast cancer patients. We assessed SRCIN1-related roles and pa
Externí odkaz:
https://doaj.org/article/0673084bb3234102bbb1eac3a4244be8
Autor:
Ruo-Kai Lin, Chih-Ming Su, Shih-Yun Lin, Le Thi Anh Thu, Phui-Ly Liew, Jian-Yu Chen, Huey-En Tzeng, Yun-Ru Liu, Tzu-Hao Chang, Cheng-Yang Lee, Chin-Sheng Hung
Publikováno v:
Molecular Medicine, Vol 28, Iss 1, Pp 1-20 (2022)
Abstract Background Approximately 25% of patients with early-stage breast cancer experience cancer progression throughout the disease course. Alterations in TMEM240 in breast cancer were identified and investigated to monitor treatment response and d
Externí odkaz:
https://doaj.org/article/c18ac44cbf4f4316a04a4f5d72dbce83
Autor:
Muhamad Ansar, Le Thi Anh Thu, Chin-Sheng Hung, Chih-Ming Su, Man-Hsu Huang, Li-Min Liao, Yu-Mei Chung, Ruo-Kai Lin
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Epigenetic alterations play a pivotal role in cancer treatment outcomes. Using the methylation array data and The Cancer Genome Atlas (TCGA) dataset, we observed the hypomethylation and upregulation of thiosulfate sulfurtransferase–like domain cont
Externí odkaz:
https://doaj.org/article/5a5af9d53e984acca59269764a95fe8f
Autor:
Chih‐Ming Su, Tung‐Wei Hsu, Hsin‐An Chen, Wan‐Yu Wang, Chih‐Yang Huang, Chih‐Chiang Hung, Ming‐Hsin Yeh, Yen‐Hao Su, Ming‐Te Huang, Po‐Hsiang Liao
Publikováno v:
Journal of Cellular Physiology. 238:829-841
Autor:
Chia-Hung Hsu, Hon-Ping Ma, Jiann Ruey Ong, Ming-Shou Hsieh, Vijesh Kumar Yadav, Chi-Tai Yeh, Tsu-Yi Chao, Wei-Hwa Lee, Wen-Chien Huang, Kuang-Tai Kuo, Iat-Hang Fong, Chih-Cheng Lin, Chih-Ming Su
Publikováno v:
Disease Markers. 2022:1-16
Background. Despite therapeutic advancements, metastasis remains a major cause in breast cancer-specific mortality. Breast cancer cells are susceptible to oxidative damage and exhibit high levels of oxidative stress, including protein damage, DNA dam
Autor:
Ming Te Huang, Chien Yi Chiang, Kuan Chou Chen, Tung Wei Hsu, Hsin An Chen, Chih Ming Su, Shian Ying Sung, Chih Yang Huang, Yen-Hao Su, Po Hsiang Liao
Publikováno v:
Environmental Toxicology. 36:1278-1287
AXL which is a chemosensitizer protein for breast cancer cells in response to epidermal growth factor receptor-tyrosine kinase inhibitor and suppresses tumor growth. The clinical information show nuclear factor I (NFI)-C and NFI-X expression correlat
Autor:
Yu Ting Yeh, Jiefeng Zhou, Chih Ming Su, Shin Han Tsai, Hsin An Chen, Shicong Du, Haoran Wu, Chang Wei Li
Publikováno v:
OncoTargets and Therapy. 13:8629-8639
Background Breast cancer is one of the most prevalent gynecologic malignancies worldwide. Despite the high sensitivity in response to chemotherapy, drug resistance occurred frequently in clinical treatment. Cryptotanshinone (CTS) is a herbal medicine
Autor:
Tung-Wei Hsu, Hsin-An Chen, Po-Hsiang Liao, Yen-Hao Su, Ching-Feng Chiu, Chih-Yang Huang, Yu-Jung Lin, Chih-Chiang Hung, Ming-Hsin Yeh, Shian-Ying Sung, Chih-Ming Su
Publikováno v:
Aging. 14(16)
Distant metastasis is the leading cause of death in patients with breast cancer. Despite considerable treatment advances, the clinical outcomes of patients with metastatic breast cancer remain poor. CSCs can self-renew, enhancing cancer progression a
Publikováno v:
Breast cancer (Tokyo, Japan). 29(5)
Patients with breast cancer encounter difficulties in making surgical treatment decisions. Shared decision-making (SDM) with patient decision aids (PDAs) can minimize patients' decisional conflicts. However, the effect of PDAs in Asia remains inconcl
Autor:
Le Thi Anh Thu, Shih-Yun Lin, Chih-Ming Su, Ruo-Kai Lin, Phui-Ly Liew, Jian-Yu Chen, Chin Sheng Hung, Huey-En Tzeng
Background:Approximately 25% of patients with early-stage breast cancer experience cancer progression throughout the disease course. Alterations in TMEM240 in breast cancer were identified and investigated to monitor treatment response and disease pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11152afdf14f5db96c5243a4c726d87a
https://doi.org/10.21203/rs.3.rs-1021973/v1
https://doi.org/10.21203/rs.3.rs-1021973/v1